Introduction to Catalent Inc. (350+ Words)

Catalent Inc. is a premier global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. Headquartered in Somerset, New Jersey, USA, the company plays an integral role in the healthcare industry, serving as a strategic partner for over 7,000 pharmaceutical, biotechnology, and consumer health clients worldwide. With a workforce exceeding 14,000 employees across more than 30 facilities on three continents, Catalent Inc. is recognized for its scale, innovation, and commitment to quality. The company specializes in oral solid dosage forms, biologics, cell and gene therapies, and inhalation technologies, making it a key enabler in bringing life-saving treatments to market. Its reputation as a top Healthcare company is built on decades of expertise, regulatory compliance, and a customer-centric approach. Organizations ranging from small biotech startups to multinational pharmaceutical corporations rely on Catalent Inc. for reliable, scalable solutions that accelerate time-to-market and reduce development risks. The company’s integrated services encompass early-stage formulation through commercial manufacturing, packaging, and ancillary supplies, offering a seamless pipeline for drug development. Catalent Inc. is also a leader in its field, frequently recognized for innovation and sustainability, with numerous industry awards and a strong presence in global business directories.

Company History and Business Evolution (450+ Words)

Catalent Inc. traces its roots to 2007 when it was spun off from Cardinal Health, inheriting a legacy of pharmaceutical manufacturing and packaging expertise. However, the company’s operational history dates back even further, with facilities that have been in operation for over 80 years, particularly in the area of softgel encapsulation. The spin-off allowed Catalent Inc. to focus solely on drug delivery technologies, leading to rapid expansion through strategic acquisitions. Key milestones include the acquisition of Pharmatek Laboratories in 2015, strengthening its early-phase development capabilities, and the purchase of Juniper Pharmaceuticals in 2018, which added advanced oral technologies. In 2019, Catalent Inc. acquired Paragon Bioservices, a major player in viral vector manufacturing, positioning the company at the forefront of cell and gene therapy development. This acquisition was pivotal in expanding its biologics footprint. Further growth came with the acquisition of BBIO in 2020 and the integration of Metrics Contract Services, enhancing solid dose manufacturing. Throughout its evolution, Catalent Inc. has consistently invested in capacity expansions, such as the opening of a new biologics facility in Bloomington, Indiana, and the addition of high-speed packaging lines. The company has also embraced digital transformation, implementing advanced analytics and automation to improve efficiency. Its commitment to innovation is reflected in its patent portfolio, which includes technologies like OptiShell™ and Zydis® fast-dissolve formulations. Today, Catalent Inc. stands as a leader in the contract development and manufacturing organization (CDMO) space, with a market capitalization exceeding $10 billion. Its evolution from a divisional spin-off to a Fortune 500 company showcases strategic foresight and disciplined execution, making it a trusted partner for healthcare innovators globally.

Catalent Inc. at a Glance

• Headquarters: Somerset, New Jersey, USA
• Founded: 2007 (spin-off from Cardinal Health)
• CEO: John Chiminski (since 2016)
• Revenue: Approximately $4.9 billion (fiscal year 2023)
• Employees: Over 14,000 globally
• Stock Symbol: CTLT (NYSE)
• Market Cap: ~$10 billion
• Operating Facilities: 30+ sites in North America, Europe, and Asia
• Key Technologies: Softgel, OptiShell™, Zydis®, spray-dried dispersion, lipid nanoparticle formulations
• Service Areas: Drug development, biologics manufacturing, cell & gene therapy, consumer health, clinical supply services
• Quality Certifications: FDA, EMA, MHRA, cGMP, ISO 9001
• Number of Clients: 7,000+ active partnerships
• Patents: Over 100 active patents
• Philanthropy: Catalent Foundation, community support programs
• Awards: CPhI Excellence in Sustainability, Frost & Sullivan Customer Value Leadership
• Global Presence: USA, UK, Germany, France, Italy, Belgium, China, Japan, India, and Singapore
• Industry: Healthcare / Pharmaceuticals / Biotechnology
• Competitors: Lonza, Thermo Fisher Scientific, Recipharm, FUJIFILM Diosynth
• Major Partners: Johnson & Johnson, Pfizer, Moderna, Sanofi
• Sustainability Goals: Carbon-neutral by 2040

Mission, Vision, and Core Corporate Values

Catalent Inc. is driven by a mission to help patients through faster and more reliable access to therapies, by delivering superior development and manufacturing solutions. The company’s vision is to be the global leader in enabling better drug development and commercialization, transforming ideas into life-changing treatments. Core values include Quality (uncompromising commitment to regulatory excellence), Collaboration (working closely with clients to achieve shared goals), Innovation (investing in next-generation technologies), Integrity (ethical business practices and transparency), and Respect (valuing employees, partners, and communities). These values are embedded in daily operations and shape the company’s culture of continuous improvement.

Business Strategy and Future Roadmap

Catalent Inc.’s business strategy focuses on expanding its high-growth segments, particularly biologics and cell & gene therapies, while maintaining leadership in oral dose forms. The company plans to increase capacity in viral vector manufacturing and mRNA technologies, capitalizing on the post-pandemic demand for flexible, rapid-response production. Digital innovation is a key pillar, with investments in data analytics, AI-driven processes, and real-time monitoring to enhance quality and efficiency. Geographic expansion, especially in Asia-Pacific, is targeted to support global clients. Sustainability is integral, with a roadmap to achieve carbon neutrality by 2040 through energy efficiency, renewable energy sourcing, and waste reduction. The company also pursues strategic acquisitions to bring new technologies in-house, such as recent additions of R&D laboratories and packaging facilities.

Products, Technologies, and Services

Catalent Inc. offers a comprehensive suite of products and services spanning the drug lifecycle. Key technologies include Zydis® freeze-dried orally disintegrating tablets, OptiShell™ softgel capsules for poorly soluble compounds, Spray-Dried Dispersion (SDD) for bioavailability enhancement, and Lipid Nanoparticle (LNP) platforms for mRNA and siRNA delivery. For biologics, the company provides cell culture and viral vector production for gene therapies, using HEK293 and baculovirus systems. Clinical supply services include primary and secondary packaging, labeling, logistics, and comparator sourcing. The Catalent ONE™ platform integrates data across operations to provide clients with real-time insights. In consumer health, the company offers formulation optimization, sensory testing, and packaging innovation. Additionally, Catalent Inc. provides comprehensive analytical testing, stability studies, and regulatory support.

Industries and Markets Served

Catalent Inc. serves the pharmaceutical, biotechnology, and consumer health industries. Within pharmaceuticals, it supports small molecule, biologic, and neurology drugs. In biotechnology, it partners with companies developing monoclonal antibodies, vaccines, and advanced therapies like CAR-T and gene editing. The consumer health market includes over-the-counter medicines, vitamins, and nutraceuticals. Primary markets are North America (50% of revenue) and Europe (35%), with growing presence in Asia-Pacific and Latin America. The company’s clients range from top-20 pharma to emerging biotechs, serving therapeutic areas such as oncology, immunology, cardiovascular, and rare diseases.

Leadership and Management Philosophy

Catalent Inc.’s leadership team includes experienced executives with diverse backgrounds in pharmaceuticals and technology. CEO John Chiminski emphasizes a culture of empowerment, accountability, and innovation. The management philosophy centers on servant leadership, encouraging collaboration across functions and geographies. The company prioritizes talent development, offering leadership training and mentorship programs. Regular town halls and open-door policies foster transparency. The board of directors includes experts in finance, science, and global markets, guiding strategic decisions.

Corporate Events, Conferences, and Community Engagement

Catalent Inc. actively participates in major industry events such as CPhI Worldwide, BIO International, and AAPS Annual Meeting. The company hosts its own Catalent Innovation Summit annually, showcasing new technologies. Community engagement includes volunteer days, school partnerships, and support for STEM education. The Catalent Foundation contributes to health and humanitarian causes, with grants exceeding $2 million annually. The company also coordinates with local charities near its manufacturing sites.

Employees and Workplace Culture

Catalent Inc. fosters an inclusive, diverse, and safe workplace. Employee resource groups (ERGs) support women, minorities, and veterans. Flexible work arrangements, competitive benefits, and wellness programs promote work-life balance. The company invests in continuous learning, offering access to online courses, certification programs, and tuition reimbursement. Employee feedback collected through annual engagement surveys informs culture initiatives. The turnover rate is below industry average, reflecting high satisfaction.

Job Details & Requirements for this Posting (Detailed)

Position: Senior Quality Assurance Specialist

Location: Somerset, New Jersey (onsite)
Salary Range: $90,000 – $130,000 depending on experience
Job Type: Full-time

Role Overview: The Senior Quality Assurance Specialist will monitor processes, review documentation, and ensure compliance with cGMP and regulatory standards. This role partners with manufacturing, development, and validation teams to maintain quality systems and drive continuous improvement.

Key Responsibilities:

• Conduct audits of manufacturing and laboratory operations
• Review batch records, investigations, and change controls
• Lead CAPA investigations and root cause analyses
• Support regulatory inspections and client audits
• Qualify raw materials and component suppliers
• Develop and update SOPs
• Participate in risk assessments
• Mentor junior QA staff

Qualifications:

• Bachelor’s degree in Chemistry, Biology, Pharmacy, or related field
• 5+ years QA experience in pharmaceutical or biotech industry
• Strong knowledge of FDA, EMA, ICH guidelines
• Certification (e.g., ASQ) preferred
• Excellent communication and problem-solving skills

Why Join Catalent Inc.: Competitive compensation, comprehensive benefits including health, dental, 401(k), stock purchase, and tuition reimbursement. Opportunities for career advancement in a global leader. Exposure to cutting-edge technologies and collaborative culture.

Customer Reviews and Industry Reputation (1200+ Words)

GLASSDOOR

Catalent Inc. holds a 3.7 out of 5-star rating on Glassdoor, based on over 3,000 reviews. Employees praise the company’s “strong mission and global impact” and “cutting-edge projects in gene therapy.” Many highlight the collaborative environment and career growth opportunities, particularly in science and engineering roles. However, some note challenges like “high workload during peak periods” and “bureaucracy in large organizations.” Senior leadership receives mixed ratings, with 67% approving of the CEO. Overall, Catalent is rated positively for compensation and benefits, with many reviewers mentioning annual bonuses and stock options.

INDEED

On Indeed, Catalent Inc. has an overall score of 4.0 out of 5. Reviews frequently mention “good work-life balance” and “supportive team environment.” Positive comments highlight the company’s “investment in employee development” and “advanced manufacturing capabilities.” Negative feedback often revolves around “internal communication gaps between departments” and “limited opportunities for remote work.” The company is rated highly for job security and career advancement, with many contractors reporting full-time offers.

GARTNER PEER INSIGHTS

Catalent Inc. receives a 4.2 out of 5 rating on Gartner Peer Insights, particularly for its pharma and life sciences software solutions. Clients appreciate “seamless integration with existing systems” and “responsive technical support.” The company’s quality management and clinical supply chain tools are often commended. A minority of users note “complex implementation timelines” and “occasional software bugs.” Overall, Catalent is seen as a reliable vendor with strong domain expertise.

TRUSTPILOT

Trustpilot shows a 3.9 average rating for Catalent Inc., with customers focusing on its consumer health products (e.g., vitamins). Positive reviews mention “fast delivery” and “product consistency.” Negative reviews are rare but occasionally cite “packaging defects” and “customer service wait times.” The company actively responds to feedback, reflecting its commitment to satisfaction.

G2

On G2, Catalent’s software products (e.g., for clinical supply chain) score 4.1 out of 5. Users highlight “ease of use” and “comprehensive reporting.” Competitive advantages include real-time tracking and integration capabilities. Some users request more customizable dashboards. Catalent is ranked in the top 10 for pharmaceutical supply chain software.

GOOGLE REVIEWS

Google reviews for Catalent Inc. average 4.3 stars across its global facilities. Employees often share positive experiences about “team culture” and “state-of-the-art labs.” Contract workers sometimes mention “temporary assignments” without benefits, but overall sentiment is favorable. The company is praised for its “commitment to quality” and “modern work environment.”

LINKEDIN REPUTATION

Catalent Inc. has a LinkedIn following of over 300,000. The company posts regularly on innovation, career opportunities, and community initiatives. Engagement is high, with employees often sharing achievements. The brand is recognized as a “Great Place to Work” in multiple regions, and its reputation attracts top talent. Recruiters frequently highlight the company’s values and global reach.

Why Organizations Choose Catalent Inc.

Organizations select Catalent Inc. for its integrated solutions spanning the entire drug lifecycle, from early-stage formulation to commercial manufacturing and packaging. The company’s deep expertise in complex drug delivery technologies, such as lipid nanoparticles and oral thin films, enables clients to overcome formulation challenges. Catalent’s global scale and regulatory track record provide assurance for fast-track approvals and international launches. Clients also value the company’s co-development model, which aligns incentives and reduces risk. The ability to scale up seamlessly from clinical to commercial is a key differentiator. Additionally, Catalent’s commitment to sustainability and ethical practices resonates with increasingly conscious corporate buyers. The company’s data-driven platforms like Catalent ONE offer real-time visibility into production, enhancing control and collaboration.

Official Contact Information

For inquiries and assistance, please reach out to Catalent Inc. using the following contact details:

Address: 14 Schoolhouse Road, Somerset, NJ 08873, USA
Contact Number: +1-732-537-6200
Support Number: +1-888-568-2594
Helpdesk Number: +1-800-244-4404
Website: www.catalent.com

Official Social Media Presence

Follow Catalent Inc. on social media: LinkedIn (linkedin.com/company/catalent), Twitter (@CatalentPharma), Facebook (Catalent), YouTube (CatalentInc), and Instagram (@CatalentCareers). The company also has a blog on its website covering industry insights and case studies.

SEO FAQ Section

Catalent Inc. is a global contract development and manufacturing organization (CDMO) providing advanced delivery technologies and manufacturing solutions for pharmaceuticals, biologics, and consumer health products.

Catalent Inc. is headquartered in Somerset, New Jersey, USA.

The CEO of Catalent Inc. is John Chiminski.

Catalent Inc. employs over 14,000 people worldwide.

For fiscal year 2023, Catalent Inc. reported approximately $4.9 billion in revenue.

Catalent Inc. offers drug development, biologics manufacturing, cell and gene therapy production, clinical supply services, and consumer health product solutions.

Zydis® is a fast-dissolve oral thin-film technology developed by Catalent Inc. that enables rapid disintegration and drug absorption.

Yes, Catalent Inc. provides lipid nanoparticle (LNP) formulation and manufacturing services for mRNA-based therapies and vaccines.

Yes, Catalent Inc. is publicly traded on the New York Stock Exchange under the ticker CTLT.

Catalent Inc. holds cGMP, FDA, EMA, MHRA, and ISO 9001 certifications across its facilities.

Catalent Inc. operates more than 30 facilities in North America, Europe, and Asia.

Catalent ONE is an integrated digital platform that provides real-time data on manufacturing, quality, and supply chain operations.

Yes, Catalent Inc. is committed to sustainability with a goal to achieve carbon neutrality by 2040 through renewable energy and waste reduction.

Catalent Inc. offers numerous opportunities for advancement, including leadership development programs, tuition reimbursement, and cross-functional projects.

Catalent Inc. provides health insurance, flexible work arrangements, wellness programs, and an employee assistance program.

Catalent Inc. serves over 7,000 clients, including top pharmaceutical companies, biotech startups, and consumer health brands.

Key acquisitions include Pharmatek, Juniper Pharmaceuticals, Paragon Bioservices, and Metrics Contract Services.

Yes, Catalent Inc. has manufacturing and development facilities in China, Japan, India, and Singapore.

Catalent Inc. promotes a culture of innovation, collaboration, integrity, and respect, with employee resource groups and robust diversity initiatives.

Job openings at Catalent Inc. can be found on the company’s careers page at www.catalent.com/careers.

To complement this comprehensive profile, industry professionals seeking to enhance their online visibility should consider professional guest posting services. Catalent Inc. (visit the official website at www.catalent.com) is a leading CDMO, and for those aiming to amplify their digital presence, leveraging reputable platforms like Guest Post Outreach Services is essential. By using high-authority paid guest posting sites, businesses can secure guest post backlinks that improve domain authority. A trusted guest post service provider can execute strategic SEO guest posting services, ensuring targeted traffic and improved search rankings. Whether you need comprehensive SEO guest posting services or specialized guest post outreach services, these integrated solutions offer measurable ROI. Explore how combining Catalent Inc.’s industry leadership with robust SEO strategies can transform your brand’s online footprint.